CABL Study: Circulating Tumour DNA (ctDNA) as a Biomarker of Response to Anti-Cancer Therapy in B-cell NH lymphoma

Non-Hodgkin Lymphoma (NHL) is a heterogeneous group of diseases with over 60 specific subtypes. While significant advances have been made in the sub-classification of NHL, methods of disease assessment have remained relatively unchanged. Additionally, although frontline treatment options are similar across subtypes of NHL, response can vary, necessitating close monitoring after therapy. In this study, serial plasma collections will be analysed for circulating tumour DNA (ctDNA) content with the aim of assessing this as an easily accessible surrogate of tumour burden. The performance of ctDNA will be compared to that of PET scanning to assess the relative usefulness of these two methods for NHL monitoring. A baseline, pre-treatment tumour sample (Fresh-frozen or FFPE index lesion) will also be collected and analysed using the Peter MacCallum PanHaem NGS panel at no cost to participants. The results will be returned in real-time to clinicians.

Project Information

Institution:

Epworth HealthCare

Specialities:

Haematology

Oncology

Other (specify below)

End date:

Suitability:

Senior clinician

Parts of research done:

Literature review, Research proposal, Ethics approval

Positions Available:

Addition of sites for study recruitment

Current Funding:

Epworth Medical Foundation

Website

  • Twitter

Contact

Dr Costas Yannakou

Please fill out the form below to express your interest in this research project. It is free to contact a project owner and express interest in a project. We recommend writing a detailed message regarding why you are interested in the project (e.g. what skills you can bring to the team) or what information you are seeking (e.g. detail regarding the study duration). All information you provide will be shared with the primary researcher, including your contact details. Thank you for your interest in this project.

LINKS:

ABOUT:

Melbourne,

VIC. 3002

Australia

 

0424 730 627

info@theresearchcollab.com

ABN: 77 640 321 295

CONNECT WITH US:

  • Twitter
  • White Facebook Icon
  • White Instagram Icon
  • LinkedIn - White Circle